Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q2 2026 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q3 2026 | 1 | -$0.31 | -$0.31 | -$0.31 |
| Q4 2026 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q1 2027 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q2 2027 | 1 | -$0.43 | -$0.43 | -$0.43 |
Connect Biopharma Holdings Ltd last posted its earnings results on Wednesday, August 13th, 2025. The company reported $-0.23 earnings per share for the quarter, missing analysts' consensus estimates of $-0.22 by $0.01. The company had revenue of 48.00 K for the quarter and had revenue of 26.03 M for the year. Connect Biopharma Holdings Ltd has generated $0 earnings per share over the last year ($-0.28 diluted earnings per share) and currently has a price-to-earnings ratio of -4.46. Connect Biopharma Holdings Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2025 | Q2 2025 | -$0.22 | -$0.23 | -0.01 | $48.00 K | $48.00 K |
| 03/31/2025 | Q4 2024 | -$0.27 | -$0.42 | -0.15 | N/A | $1.91 M |
| 06/28/2024 | Q2 2024 | N/A | $0.14 | N/A | $151.94 M | $24.12 M |
| 04/16/2024 | Q4 2023 | -$0.03 | -$0.52 | -0.49 | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$0.56 | N/A | N/A | $0 |
| 04/11/2023 | Q4 2022 | -$3.58 | -$1.03 | 2.55 | N/A | $0 |
| 10/11/2022 | Q2 2022 | N/A | -$13.47 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2021 | -$4.38 | -$1.05 | 3.33 | N/A | $0 |
| 08/31/2021 | Q2 2021 | -$2.36 | -$3.10 | -0.74 | N/A | $0 |
| 12/31/2020 | Q4 2020 | N/A | -$0.00 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.00 | N/A | N/A | $0 |
| 12/31/2019 | Q4 2019 | N/A | -$1.51 | N/A | N/A | $0 |
| 06/30/2019 | Q2 2019 | N/A | -$1.51 | N/A | N/A | $0 |
The conference call for Connect Biopharma Holdings Ltd's latest earnings report can be listened to online.
The conference call transcript for Connect Biopharma Holdings Ltd's latest earnings report can be read online.
Connect Biopharma Holdings Ltd (:CNTB) has a recorded annual revenue of $26.03 M.
Connect Biopharma Holdings Ltd (:CNTB) has a recorded net income of $-15,628,000.Connect Biopharma Holdings Ltd has generated $-0.28 earnings per share over the last four quarters.
Connect Biopharma Holdings Ltd (:CNTB) has a price-to-earnings ratio of -4.46 and price/earnings-to-growth ratio is 0.03.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED